Alzheimer's disease trials recruiting in Virginia

All Alzheimer's disease trials nationally

Cities in Virginia

Recruiting trials in Virginia

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07170150 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Virginia: Arlington, Fairfax
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Virginia: Fairfax
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Virginia: Richmond
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Virginia: Vienna
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Falls Church, Richmond
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · Virginia: Richmond
• Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers
  NCT07413406 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · Virginia: Virginia Beach
• Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
  NCT04436081 · Phase: Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Virginia: Norfolk
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Virginia: Arlington
• Open-label Extension Study in Participants With Early Alzheimer's Disease
  NCT07105709 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Virginia: Fairfax
• Randomized Controlld Trial of Dementia Education Resources for Action
  NCT07545577 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Fairfax
• Rifaximin SSD in Dementia Trial
  NCT06718686 · Phase: Phase 1, Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · Virginia: Richmond
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
  NCT07177352 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Virginia: Arlington, Fairfax, Richmond
• Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
  NCT05565833 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · Virginia: Charlottesville
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
  NCT06847321 · Phase: Phase 2 · Ages: 55 Years to 80 Years · Sex: All (male and female) · Virginia: Charlottesville, Fairfax
• The Role of the Locus Coeruleus in Age-related Distractibility
  NCT05574634 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Virginia: Blacksburg
• mHealth Intervention for Pain Self Management
  NCT07332377 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Virginia: Richmond